Form 4 for GH Guardant Health, Inc.
Accepted 2026-07-02 18:09:02 ET · period of report 2026-06-30 · accession 0001753159-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-07-02 18:09 | 2026-06-30+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | +36.5K | 1.92M | +2% | $0 |
| DMI | 2026-07-02 18:09 | 2026-06-30+ | GH | Talasaz AmirAli | Co-CEO, Dir | F - Tax | $169.17 | -18.5K | 1.90M | -1.0% | -$3.13M |
| DM | 2026-07-02 18:09 | 2026-06-30+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | -36.5K | 58.3K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | M | A | 2,817 | $0.00 | 1,884,153 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | |
| 2 | Common | Common Stock | 2026-06-30 | F | D | 1,428 | $150.03 | 1,882,725 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Common | Common Stock | 2026-07-01 | M | A | 23,997 | $0.00 | 1,906,722 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | |
| 4 | Common | Common Stock | 2026-07-01 | M | A | 9,715 | $0.00 | 1,916,437 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | |
| 5 | Common | Common Stock | 2026-07-01 | F | D | 17,086 | $170.77 | 1,899,351 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 6 | Derivative | Restricted Stock Units | 2026-06-30 | M | D | 2,817 | $0.00 | 5,634 | D | $0.00 · — to — | 2,817 Common Stock | (F2) This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. (F3) Not applicable for Restricted Stock Units. |
| 7 | Derivative | Restricted Stock Units | 2026-07-01 | M | D | 23,997 | $0.00 | 47,995 | D | $0.00 · — to — | 23,997 Common Stock | (F4) This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |
| 8 | Derivative | Restricted Stock Units | 2026-07-01 | M | D | 9,715 | $0.00 | 58,296 | D | $0.00 · — to — | 9,715 Common Stock | (F5) This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |